Market Indices
Latest News
 |
Key Points- Investors who suffered losses with Atara Biotherapeutics, Inc. may...April 10, 2026 ATRA -3.73% |
| ||
| ||
| ||
|
Price Targets
Bobby Brooks from Northland Securities issued a price target of $14.00 for RELL on 2026-04-10 13:04:20.The adjusted price target was set to $14.00.At the time of the announcement,
April 10, 2026 RELL -7.48%
from Canaccord Genuity issued a price target of $22.00 for SPIR on 2026-04-10 11:05:34.The adjusted price target was set to $22.00.At the time of the announcement, SPIR...
April 10, 2026 SPIR 20.31%
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX 3.54%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO -4.10%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN -0.97%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CUE Cue Biopharma, Inc. | 0.50
71.36% | ||||||||||||||||||
| MAPSW WM Technology Inc | 0.01
51.52% | ||||||||||||||||||
| QSIAW Quantum-Si incorporated | 0.11
40.99% | ||||||||||||||||||
| TPST Tempest Therapeutics, Inc | 2.05
29.75% | ||||||||||||||||||
| MAXN Maxeon Solar Technologies | 1.71
29.55% | ||||||||||||||||||
| AIXI Xiao-I Corporation | 1.22
23.07% | ||||||||||||||||||
| SCLXW SCLXW | 0.09
22.22% | ||||||||||||||||||
| SPIR Spire Global, Inc. | 21.56
20.31% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -1.12%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -5.55%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -2.33%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -1.54%